NEW YORK (GenomeWeb) – Meridian Bioscience today reported its fiscal fourth quarter and fiscal year revenues grew 1 percent and 3 percent, respectively.

For the quarter ended Sept. 30, the Cincinnati, Ohio-based molecular diagnostics manufacturer saw fourth quarter revenue increase from $46.7 million to $47.1 million, edging out analysts' consensus estimate of $46.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers examine the gap in funding between researchers and research institutions, ScienceInsider reports

By sequencing two ancient dog genomes, researchers from the US and Germany suggest that dogs were domesticated in a single event, the Washington Post reports.

In Genome Research this week: population dynamics of E. coli infection, lncRNA expression changes in macaque aging, and more.

Noninvasive prenatal testing can uncover pregnancies at risk of miscarriage, New Scientist reports.